Sprint Bioscience's Upcoming Conferences and Investor Events

SPRINTPressmeddelande2026-08-13 12:15

Sprint Bioscience AB (publ) summarizes below the company's upcoming meetings with potential partners and investors during the second half of 2026. The list is subject to change and is available on the company's website.

International Partnering Conferences:
8-9 September 2026
Nordic Life Science Days
https://nlsdays.com/

14-16 September 2026
IPLS, International Partnering in Lifescience Society Annual Conference
Stockholm, Sweden
https://ipls.online/events/

7-9 October 2026
Bio Japan, Yokohama, Japan
https://jcd-expo.jp/en/

9-11 November 2026
BIO-Europe, Cologne, Germany
https://informaconnect.com/bioeurope/

Investor meetings:
1 October 2026
Swiss Nordic Biotech, Zürich, Switzerland
https://www.swissnordicbio.com/

4-5 November 2026
BioStock Life Science Summit. Lund, Sweden
https://biostock.se/en/event/life-science-summit-2026/

Scientific Conference:
18 November 2026
38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Barcelona, Spain
https://event.eortc.org/ena2026/

For more information and to view recorded presentations, please visit:
https://sprintbioscience.com/en/calendar/
https://sprintbioscience.com/en/movie/

About Sprint Bioscience AB (publ)

Sprint Bioscience develops small molecule first-in-class drug programs with a focus on oncology. With a fragment-based drug development method, the company develops drug programs in a time- and resource-efficient manner. The programs enter partnerships through licensing agreements, asset acquisitions, or research collaborations with global pharmaceutical companies during the pre-clinical phase and the company has successfully formed several agreements. The Sprint Bioscience share is listed on the Nasdaq First North Premier Growth Market and trades under the ticker symbol SPRINT. The company is based in Stockholm with operations located in Huddinge. Further information is available on the company website; www.sprintbioscience.com. Certified Advisor is FNCA Sweden AB, www.fnca.se.